BFEC
AUPH icon

Benjamin F. Edwards & Company’s Aurinia Pharmaceuticals AUPH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6K Hold
1,130
– – ﹤0.01% 1821
2024
Q1 		$6K Hold
1,130
– – ﹤0.01% 1804
2023
Q4 		$10K Hold
1,130
– – ﹤0.01% 1647
2023
Q3 		$9K Hold
1,130
– – ﹤0.01% 1408
2023
Q2 		$11K Hold
1,130
– – ﹤0.01% 1385
2023
Q1 		$12K Hold
1,130
– – ﹤0.01% 1368
2022
Q4 		$5K Sell
1,130
-15,000
-93% -$87K ﹤0.01% 1553
2022
Q3 		$121K Buy
16,130
+5,000
+45% +$43.3K 0.01% 807
2022
Q2 		$112K Hold
11,130
– – 0.01% 826
2022
Q1 		$138K Hold
11,130
– – 0.01% 781
2021
Q4 		$255K Hold
11,130
– – 0.01% 618
2021
Q3 		$246K Hold
11,130
– – 0.01% 607
2021
Q2 		$144K Buy
11,130
+2,000
+22% +$25.5K 0.01% 740
2021
Q1 		$119K Sell
9,130
-2,000
-18% -$29K 0.01% 796
2020
Q4 		$154K Buy
11,130
+1,130
+11% +$16.4K 0.01% 709
2020
Q3 		$147K Hold
10,000
– – 0.01% 664
2020
Q2 		$163K Hold
10,000
– – 0.01% 615
2020
Q1 		$145K Hold
10,000
– – 0.01% 586
2019
Q4 		$203K Hold
10,000
– – 0.01% 590
2019
Q3 		$53K Buy
10,000
+3,000
+43% +$18.2K ﹤0.01% 911
2019
Q2 		$46K Buy
7,000
+5,000
+250% +$31.9K ﹤0.01% 927
2019
Q1 		$13K Hold
2,000
– – ﹤0.01% 1247
2018
Q4 		$14K Hold
2,000
– – ﹤0.01% 1181
2018
Q3 		$13K Hold
2,000
– – ﹤0.01% 1211
2018
Q2 		$11K Buy
+2,000
New +$11.2K ﹤0.01% 1243

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Benjamin F. Edwards & Company's AUPH Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2024 at 1,130 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Benjamin F. Edwards & Company first reported a position in AUPH in Q2 2018 and has held it in 25 quarters since. The position peaked at $255K in Q4 2021. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • Benjamin F. Edwards & Company held 1,130 shares of Aurinia Pharmaceuticals worth $6K as of Q2 2024.
  • Benjamin F. Edwards & Company left its Aurinia Pharmaceuticals share count unchanged in Q2 2024.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1821 holding.
  • Benjamin F. Edwards & Company first reported a position in Aurinia Pharmaceuticals in Q2 2018 and has held it in 25 quarters since.
  • Benjamin F. Edwards & Company's Aurinia Pharmaceuticals position peaked at $255K in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.